Objective Physical Activity and Self-Reported Quality of Life in Patients Receiving Palliative Chemotherapy

Journal of Pain and Symptom Management

Volumn 33, Issue 6, 2007, Pages 676-685

  Dahele, Max ^a   Skipworth, Richard J E ^a   Wall, Lucy ^a   Voss, Anne ^a   Preston, Tom ^a   Fearon, Kenneth C H ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

cachexia; Cancer; chemotherapy; physical activity; quality of life

Indexed keywords

ANTIINFECTIVE AGENT; CAPECITABINE; CISPLATIN; EPIRUBICIN; FLUOROURACIL; PLATINUM COMPLEX;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; MALE; PALLIATIVE THERAPY; PHYSICAL ACTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; PALLIATIVE CARE; QUALITY OF LIFE; SELF ASSESSMENT (PSYCHOLOGY);

EID: 34249086954     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2006.09.024     Document Type: Article

References (29)

1. Michael M., and Tannock I.F. Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment. CMAJ 158 (1998) 1727-1734
2. Burris III H.A., Moore M.J., Andersen J., et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15 (1997) 2403-2413
3. Rothenberg M.L., Abbruzzese J.L., Moore M., et al. A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer 78 (1996) 627-632
4. Dewys W.D., Begg C., Lavin P.T., et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69 (1980) 491-497
5. Andreyev H.J., Norman A.R., Oates J., et al. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. Eur J Cancer 34 (1998) 503-509
6. Moses A.W., Slater C., Preston T., et al. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90 (2004) 996-1002
7. Gibney E., Elia M., Jebb S.A., et al. Total energy expenditure in patients with small-cell lung cancer: results of a validated study using the bicarbonate-urea method. Metabolism 46 (1997) 1412-1417
8. Ainsworth B.E., Haskell W.L., Whitt M.C., et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32 (2000) S498-S504
9. World Health Organization. WHO handbook for reporting results of cancer treatment (1979), World Health Organisation, Geneva
10. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
11. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
12. Ribaudo J.M., Cella D., Hahn E.A., et al. Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire. Qual Life Res 9 (2000) 1137-1146
13. Yellen S.B., Cella D.F., Webster K., et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13 (1997) 63-74
14. Conroy T., Mercier M., Bonneterre J., et al. French version of FACT-G: validation and comparison with other cancer-specific instruments. Eur J Cancer 40 (2004) 2243-2252
15. Holtkamp K., Hebebrand J., and Herpertz-Dahlmann B. The contribution of anxiety and food restriction on physical activity levels in acute anorexia nervosa. Int J Eat Disord 36 (2004) 163-171
16. Visser M., Newman A.B., Nevitt M.C., et al. Reexamining the sarcopenia hypothesis. Muscle mass versus muscle strength. Health, Aging, and Body Composition Study Research Group. Ann NY Acad Sci 904 (2000) 456-461
17. Adamsen L., Quist M., Midtgaard J., et al. The effect of a multidimensional exercise intervention on physical capacity, well-being and quality of life in cancer patients undergoing chemotherapy. Support Care Cancer 14 (2006) 116-127
18. Ross P., Nicolson M., Cunningham D., et al. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 20 (2002) 1996-2004
19. Waldron D., O'Boyle C.A., Kearney M., Moriarty M., and Carney D. Quality-of-life measurement in advanced cancer: assessing the individual. J Clin Oncol 17 (1999) 3603-3611
20. Hakamies-Blomqvist L., Luoma M.L., Sjostrom J., et al. Timing of quality of life (QoL) assessments as a source of error in oncological trials. J Adv Nurs 35 (2001) 709-716
21. Kemmler G., Holzner B., Kopp M., et al. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30. J Clin Oncol 17 (1999) 2932-2940
22. Dimeo F., Stieglitz R.D., Novelli-Fischer U., et al. Correlation between physical performance and fatigue in cancer patients. Ann Oncol 8 (1997) 1251-1255
23. Badia X., Herdman M., and Kind P. The influence of ill-health experience on the valuation of health. Pharmacoeconomics 13 (1998) 687-696
24. Donaldson M.S. Taking stock of health-related quality-of-life measurement in oncology practice in the United States. J Natl Cancer Inst Monogr 33 (2004) 155-167
25. Johnson J.R., Williams G., and Pazdur R. Endpoints and United States Food and Drug Administration approval of oncology drugs. J Clin Oncol 21 (2003) 1404-1411
26. Ravasco P., Monteiro-Grillo I., Vidal P.M., and Camilo M.E. Cancer: disease and nutrition are key determinants of patients' quality of life. Support Care Cancer 12 (2004) 246-252
27. Dahele M., and Fearon K.C. Research methodology: cancer cachexia syndrome. Palliat Med 18 (2004) 409-417
28. Zhang K., Pi-Sunyer F.X., and Boozer C.N. Improving energy expenditure estimation for physical activity. Med Sci Sports Exerc 36 (2004) 883-889
29. Hustvedt B.E., Christophersen A., Johnsen L.R., et al. Description and validation of the ActiReg: a novel instrument to measure physical activity and energy expenditure. Br J Nutr 92 (2004) 1001-1008